This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Gossamer Bio Inc. (developing therapies for immune diseases, inflammation, and cancer) netted $295mm through its initial public offering of 19.8mm common shares (including the overallotment) at $16. The company had originally intended to sell 14mm shares.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?